Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension

Libor Kopkan, Zuzana Husková, Alexandra Sporková, Šárka Varcabová, Zuzana Honetschlägerová, Sung Hee Hwang, Hsing Ju Tsai, Bruce D. Hammock, John D. Imig, Herbert J. Kramer, Marcela Bürgelová, Alžběta Vojtíšková, Petr Kujal, Zdenka Vernerová, Luděk Červenka

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective: The present study was performed to examine whether the blood pressure (BP)-lowering effects of soluble epoxide hydrolase (sEH) inhibition in two-kidney, one-clip (2K1C) Goldblatt hypertension are nitric oxide (NO) dependent. Methods: Mice lacking the endothelial NO synthase (eNOS) gene (eNOS-/-) and their wild-type controls (eNOS+/+) underwent clipping of one renal artery. BP was monitored by radiotelemetry and the treatment with the sEH inhibitor cis-4-[4-(3-adamantan-1-yl-ureido)cyclohex-yloxy]-benzoic acid (c-AUCB) was initiated on day 25 after clipping and lasted for 14 days. Renal concentrations of epoxyeicosatrienoic acids (EETs) and their inactive metabolite dihydroxyeicosatrienoic acids (DHETs) were measured in the nonclipped kidney. Renal NO synthase (NOS) activity was determined by measuring the rate of formation of L-[14C]citruline from L-[14C]arginine. Results: Treatment with the sEH inhibitor elicited similar BP decreases that were associated with increases in daily sodium excretion in 2K1C eNOS+/+ as well as 2K1C eNOS-/- mice. In addition, treatment with the sEH inhibitor increased the ratio of EETs/DHETs in the nonclipped kidney of 2K1C eNOS+/+ as well as 2K1C eNOS-/- mice. Treatment with the sEH inhibitor did not alter renal NOS activity in any of the experimental groups. Conclusions: Collectively, our present data suggest that the BP-lowering effects of chronic sEH inhibition in 2K1C mice are mainly associated with normalization of the reduced availability of biologically active EETs in the nonclipped kidney and their direct natriuretic actions.

Original languageEnglish (US)
Pages (from-to)595-607
Number of pages13
JournalKidney and Blood Pressure Research
Volume35
Issue number6
DOIs
StatePublished - Feb 2013

Fingerprint

Epoxide Hydrolases
Renovascular Hypertension
Nitric Oxide Synthase
Antihypertensive Agents
Nitric Oxide
Kidney
Blood Pressure
Acids
Benzoic Acid
Nitric Oxide Synthase Type III
Renal Artery
Surgical Instruments
Arginine
Sodium

Keywords

  • Cytochrome P450 metabolites
  • Endothelial nitric oxide synthase
  • Epoxyeicosatrienoic acids
  • Nitric oxide
  • One-clip Goldblatt hypertension
  • Renin-angiotensin system
  • Sodium excretion
  • Soluble epoxide hydrolase
  • Two-kidney

ASJC Scopus subject areas

  • Nephrology
  • Cardiology and Cardiovascular Medicine

Cite this

Kopkan, L., Husková, Z., Sporková, A., Varcabová, Š., Honetschlägerová, Z., Hwang, S. H., ... Červenka, L. (2013). Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension. Kidney and Blood Pressure Research, 35(6), 595-607. https://doi.org/10.1159/000339883

Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension. / Kopkan, Libor; Husková, Zuzana; Sporková, Alexandra; Varcabová, Šárka; Honetschlägerová, Zuzana; Hwang, Sung Hee; Tsai, Hsing Ju; Hammock, Bruce D.; Imig, John D.; Kramer, Herbert J.; Bürgelová, Marcela; Vojtíšková, Alžběta; Kujal, Petr; Vernerová, Zdenka; Červenka, Luděk.

In: Kidney and Blood Pressure Research, Vol. 35, No. 6, 02.2013, p. 595-607.

Research output: Contribution to journalArticle

Kopkan, L, Husková, Z, Sporková, A, Varcabová, Š, Honetschlägerová, Z, Hwang, SH, Tsai, HJ, Hammock, BD, Imig, JD, Kramer, HJ, Bürgelová, M, Vojtíšková, A, Kujal, P, Vernerová, Z & Červenka, L 2013, 'Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension', Kidney and Blood Pressure Research, vol. 35, no. 6, pp. 595-607. https://doi.org/10.1159/000339883
Kopkan, Libor ; Husková, Zuzana ; Sporková, Alexandra ; Varcabová, Šárka ; Honetschlägerová, Zuzana ; Hwang, Sung Hee ; Tsai, Hsing Ju ; Hammock, Bruce D. ; Imig, John D. ; Kramer, Herbert J. ; Bürgelová, Marcela ; Vojtíšková, Alžběta ; Kujal, Petr ; Vernerová, Zdenka ; Červenka, Luděk. / Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension. In: Kidney and Blood Pressure Research. 2013 ; Vol. 35, No. 6. pp. 595-607.
@article{f2434d54ff4943dfaafb04f59a918324,
title = "Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension",
abstract = "Objective: The present study was performed to examine whether the blood pressure (BP)-lowering effects of soluble epoxide hydrolase (sEH) inhibition in two-kidney, one-clip (2K1C) Goldblatt hypertension are nitric oxide (NO) dependent. Methods: Mice lacking the endothelial NO synthase (eNOS) gene (eNOS-/-) and their wild-type controls (eNOS+/+) underwent clipping of one renal artery. BP was monitored by radiotelemetry and the treatment with the sEH inhibitor cis-4-[4-(3-adamantan-1-yl-ureido)cyclohex-yloxy]-benzoic acid (c-AUCB) was initiated on day 25 after clipping and lasted for 14 days. Renal concentrations of epoxyeicosatrienoic acids (EETs) and their inactive metabolite dihydroxyeicosatrienoic acids (DHETs) were measured in the nonclipped kidney. Renal NO synthase (NOS) activity was determined by measuring the rate of formation of L-[14C]citruline from L-[14C]arginine. Results: Treatment with the sEH inhibitor elicited similar BP decreases that were associated with increases in daily sodium excretion in 2K1C eNOS+/+ as well as 2K1C eNOS-/- mice. In addition, treatment with the sEH inhibitor increased the ratio of EETs/DHETs in the nonclipped kidney of 2K1C eNOS+/+ as well as 2K1C eNOS-/- mice. Treatment with the sEH inhibitor did not alter renal NOS activity in any of the experimental groups. Conclusions: Collectively, our present data suggest that the BP-lowering effects of chronic sEH inhibition in 2K1C mice are mainly associated with normalization of the reduced availability of biologically active EETs in the nonclipped kidney and their direct natriuretic actions.",
keywords = "Cytochrome P450 metabolites, Endothelial nitric oxide synthase, Epoxyeicosatrienoic acids, Nitric oxide, One-clip Goldblatt hypertension, Renin-angiotensin system, Sodium excretion, Soluble epoxide hydrolase, Two-kidney",
author = "Libor Kopkan and Zuzana Huskov{\'a} and Alexandra Sporkov{\'a} and Š{\'a}rka Varcabov{\'a} and Zuzana Honetschl{\"a}gerov{\'a} and Hwang, {Sung Hee} and Tsai, {Hsing Ju} and Hammock, {Bruce D.} and Imig, {John D.} and Kramer, {Herbert J.} and Marcela B{\"u}rgelov{\'a} and Alžběta Vojt{\'i}škov{\'a} and Petr Kujal and Zdenka Vernerov{\'a} and Luděk Červenka",
year = "2013",
month = "2",
doi = "10.1159/000339883",
language = "English (US)",
volume = "35",
pages = "595--607",
journal = "Kidney and Blood Pressure Research",
issn = "1420-4096",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension

AU - Kopkan, Libor

AU - Husková, Zuzana

AU - Sporková, Alexandra

AU - Varcabová, Šárka

AU - Honetschlägerová, Zuzana

AU - Hwang, Sung Hee

AU - Tsai, Hsing Ju

AU - Hammock, Bruce D.

AU - Imig, John D.

AU - Kramer, Herbert J.

AU - Bürgelová, Marcela

AU - Vojtíšková, Alžběta

AU - Kujal, Petr

AU - Vernerová, Zdenka

AU - Červenka, Luděk

PY - 2013/2

Y1 - 2013/2

N2 - Objective: The present study was performed to examine whether the blood pressure (BP)-lowering effects of soluble epoxide hydrolase (sEH) inhibition in two-kidney, one-clip (2K1C) Goldblatt hypertension are nitric oxide (NO) dependent. Methods: Mice lacking the endothelial NO synthase (eNOS) gene (eNOS-/-) and their wild-type controls (eNOS+/+) underwent clipping of one renal artery. BP was monitored by radiotelemetry and the treatment with the sEH inhibitor cis-4-[4-(3-adamantan-1-yl-ureido)cyclohex-yloxy]-benzoic acid (c-AUCB) was initiated on day 25 after clipping and lasted for 14 days. Renal concentrations of epoxyeicosatrienoic acids (EETs) and their inactive metabolite dihydroxyeicosatrienoic acids (DHETs) were measured in the nonclipped kidney. Renal NO synthase (NOS) activity was determined by measuring the rate of formation of L-[14C]citruline from L-[14C]arginine. Results: Treatment with the sEH inhibitor elicited similar BP decreases that were associated with increases in daily sodium excretion in 2K1C eNOS+/+ as well as 2K1C eNOS-/- mice. In addition, treatment with the sEH inhibitor increased the ratio of EETs/DHETs in the nonclipped kidney of 2K1C eNOS+/+ as well as 2K1C eNOS-/- mice. Treatment with the sEH inhibitor did not alter renal NOS activity in any of the experimental groups. Conclusions: Collectively, our present data suggest that the BP-lowering effects of chronic sEH inhibition in 2K1C mice are mainly associated with normalization of the reduced availability of biologically active EETs in the nonclipped kidney and their direct natriuretic actions.

AB - Objective: The present study was performed to examine whether the blood pressure (BP)-lowering effects of soluble epoxide hydrolase (sEH) inhibition in two-kidney, one-clip (2K1C) Goldblatt hypertension are nitric oxide (NO) dependent. Methods: Mice lacking the endothelial NO synthase (eNOS) gene (eNOS-/-) and their wild-type controls (eNOS+/+) underwent clipping of one renal artery. BP was monitored by radiotelemetry and the treatment with the sEH inhibitor cis-4-[4-(3-adamantan-1-yl-ureido)cyclohex-yloxy]-benzoic acid (c-AUCB) was initiated on day 25 after clipping and lasted for 14 days. Renal concentrations of epoxyeicosatrienoic acids (EETs) and their inactive metabolite dihydroxyeicosatrienoic acids (DHETs) were measured in the nonclipped kidney. Renal NO synthase (NOS) activity was determined by measuring the rate of formation of L-[14C]citruline from L-[14C]arginine. Results: Treatment with the sEH inhibitor elicited similar BP decreases that were associated with increases in daily sodium excretion in 2K1C eNOS+/+ as well as 2K1C eNOS-/- mice. In addition, treatment with the sEH inhibitor increased the ratio of EETs/DHETs in the nonclipped kidney of 2K1C eNOS+/+ as well as 2K1C eNOS-/- mice. Treatment with the sEH inhibitor did not alter renal NOS activity in any of the experimental groups. Conclusions: Collectively, our present data suggest that the BP-lowering effects of chronic sEH inhibition in 2K1C mice are mainly associated with normalization of the reduced availability of biologically active EETs in the nonclipped kidney and their direct natriuretic actions.

KW - Cytochrome P450 metabolites

KW - Endothelial nitric oxide synthase

KW - Epoxyeicosatrienoic acids

KW - Nitric oxide

KW - One-clip Goldblatt hypertension

KW - Renin-angiotensin system

KW - Sodium excretion

KW - Soluble epoxide hydrolase

KW - Two-kidney

UR - http://www.scopus.com/inward/record.url?scp=84865607664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865607664&partnerID=8YFLogxK

U2 - 10.1159/000339883

DO - 10.1159/000339883

M3 - Article

C2 - 22948718

AN - SCOPUS:84865607664

VL - 35

SP - 595

EP - 607

JO - Kidney and Blood Pressure Research

JF - Kidney and Blood Pressure Research

SN - 1420-4096

IS - 6

ER -